New Delhi: After the successful acceptance of yoga at the global platform, the government is aiming to popularise traditional medicines by showcasing ayurvedic and herbal products at different world-level forums. Given that the Ministry of Ayush is the apex body and has been tasked to promote yoga and Ayurveda, a team of experts comprising of ministry officials, as well as other stakeholders, has been scheduled to take part at a global conclave starting on Friday in the USA.
Besides, showcasing different products related to Ayurveda, yoga, herbal and natural medicine, the team members, which also comprise entrepreneurs and ayurvedic drug manufacturers, would also reach out to global leaders by presenting the efficacy of ayurvedic products. According to officials, the conclave would be an opportunity for the country to prove its credentials in Ayurveda. "It's been a precedent that anti-diabetes medicines developed in foreign countries are being introduced in India, but it's for the first time that we would be showcasing indigenously developed anti-diabetic drug to the world," an official said, adding that the CSIR-developed ant-diabetic ayurvedic drug BGR-34 would be the star attraction at the show.
"As yoga has already been included in the healthcare system of Americans, we are hopeful that ayurvedic and herbal medicines would also get a space into their wellness kit," said Sanchit Sharma, executive director of AIMIL Pharmaceuticals, who is part of the team visiting the conclave. Apart from the ayurvedic drugs developed by the CSIR, the herbal medicines developed by DRDO scientists such as Lukoskin -- a drug to treat leucoderma, would also be showcased at the Indo-US wellness conclave. The herbal products from Kerala, Tamil Nadu, Karnataka, North-eastern regions, etc would also be displayed at the conclave along with NeeriKFT, a herbal medicine used to control creatinine level among kidney patients.